Edwards Lifesciences (EW) EBIT Margin Growth (3y) (2012 - 2026)
Edwards Lifesciences (EW) EBIT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | -283.00 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -184.00 |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 1,505.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | 2,016.00 |
| 10 | Steris | 21.56 Bn | 21.13 Bn | 697.10 Mn | -3,846.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -283.00 |
| Dec 31, 2025 | -3,636.00 |
| Sep 30, 2025 | -1,073.00 |
| Jun 30, 2025 | -661.00 |
| Mar 31, 2025 | -477.00 |
| Dec 31, 2024 | -560.00 |
| Sep 30, 2024 | -390.00 |
| Jun 30, 2024 | -1,263.00 |
| Mar 31, 2024 | -528.00 |
| Dec 31, 2023 | -210.00 |
| Sep 30, 2023 | -193.00 |
| Jun 30, 2023 | 3,895.00 |
| Mar 31, 2023 | 8.00 |
| Dec 31, 2022 | 1,952.00 |
| Sep 30, 2022 | 361.00 |
| Jun 30, 2022 | 883.00 |
| Mar 31, 2022 | 510.00 |
| Dec 31, 2021 | 2,870.00 |
| Sep 30, 2021 | 234.00 |
| Jun 30, 2021 | 1,268.00 |